Wellington Management Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,298
| Closed | -$295K | – | 1952 |
|
|
2024
Q4 | $295K | Buy |
51,298
+16,547
| +48% | +$95.1K | ﹤0.01% | 1854 |
|
|
2024
Q3 | $360K | Buy |
+34,751
| New | +$360K | ﹤0.01% | 1832 |
|
|
2020
Q1 | – | Sell |
-3,614
| Closed | -$223K | – | 1950 |
|
|
2019
Q4 | $223K | Buy |
+3,614
| New | +$223K | ﹤0.01% | 1974 |
|
|
2018
Q4 | – | Sell |
-13,745
| Closed | -$1.17M | – | 2090 |
|
|
2018
Q3 | $1.17M | Sell |
13,745
-8,130
| -37% | -$694K | ﹤0.01% | 1841 |
|
|
2018
Q2 | $2.54M | Buy |
21,875
+6,539
| +43% | +$758K | ﹤0.01% | 1665 |
|
|
2018
Q1 | $1.24M | Buy |
15,336
+4,115
| +37% | +$333K | ﹤0.01% | 1854 |
|
|
2017
Q4 | $658K | Buy |
+11,221
| New | +$658K | ﹤0.01% | 1963 |
|
|
2017
Q2 | – | Sell |
-33,872
| Closed | -$1.04M | – | 2190 |
|
|
2017
Q1 | $1.04M | Sell |
33,872
-9,006
| -21% | -$277K | ﹤0.01% | 1908 |
|
|
2016
Q4 | $1.44M | Buy |
42,878
+4,921
| +13% | +$165K | ﹤0.01% | 1769 |
|
|
2016
Q3 | $1.01M | Sell |
37,957
-67,985
| -64% | -$1.81M | ﹤0.01% | 1831 |
|
|
2016
Q2 | $2.34M | Buy |
105,942
+22,926
| +28% | +$506K | ﹤0.01% | 1560 |
|
|
2016
Q1 | $2.44M | Buy |
83,016
+51,880
| +167% | +$1.52M | ﹤0.01% | 1547 |
|
|
2015
Q4 | $1.03M | Buy |
+31,136
| New | +$1.03M | ﹤0.01% | 1817 |
|
|
2015
Q2 | – | Sell |
-33,973
| Closed | -$1.04M | – | 2144 |
|
|
2015
Q1 | $1.04M | Buy |
33,973
+25,873
| +319% | +$792K | ﹤0.01% | 1840 |
|
|
2014
Q4 | $412K | Buy |
+8,100
| New | +$412K | ﹤0.01% | 2035 |
|
|
2013
Q4 | – | Sell |
-324,291
| Closed | -$7.43M | – | 2167 |
|
|
2013
Q3 | $7.43M | Sell |
324,291
-14,500
| -4% | -$332K | ﹤0.01% | 1301 |
|
|
2013
Q2 | $6M | Buy |
+338,791
| New | +$6M | ﹤0.01% | 1373 |
|